[1]郑德仁.多排螺旋CT诊断肝血管瘤及肝脏肿瘤的临床价值分析[J].医学信息,2018,31(20):160-162.[doi:10.3969/j.issn.1006-1959.2018.20.050]
 ZHENG De-ren.Clinical Value of Multi-slice Spiral CT in Diagnosis of Hepatic Hemangioma and Liver Tumor[J].Medical Information,2018,31(20):160-162.[doi:10.3969/j.issn.1006-1959.2018.20.050]
点击复制

多排螺旋CT诊断肝血管瘤及肝脏肿瘤的临床价值分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年20期
页码:
160-162
栏目:
诊疗技术
出版日期:
2018-10-15

文章信息/Info

Title:
Clinical Value of Multi-slice Spiral CT in Diagnosis of Hepatic Hemangioma and Liver Tumor
文章编号:
1006-1959(2018)20-0160-03
作者:
郑德仁
江西省上饶市玉山县中医院CT室,江西 玉山 334700
Author(s):
ZHENG De-ren
CT Room,Yushan Traditional Chinese Medicine Hospital,Shangrao City,Yushan 334700,Jiangxi,China
关键词:
原发性肝癌肝转移瘤肝血管瘤多排螺旋CT
Keywords:
Primary liver cancerLiver metastasesHepatic hemangiomaMulti-slice spiral CT
分类号:
R735.7;R730.44
DOI:
10.3969/j.issn.1006-1959.2018.20.050
文献标志码:
A
摘要:
目的 分析多排螺旋CT诊断肝血管瘤及肝脏肿瘤的临床价值。方法 选取2015年11月~2017年12月我院收治的肝血管瘤及肝脏肿瘤患者96例,根据疾病种类分为PHC组、ML组和LH组,每组32例。对所有患者的肝脏采用灌注CT型诊断监测,对比三组占位性病灶实质位置、周围实质位置以及健康肝脏实质位置灌注参数(HBF、HBV、MTT、PS、HAF)。结果 ①占位性病灶实质位置:PHC组的HBF和HAF均大于其他两组(P<0.05),PHC组和LH组的HBV均大于ML组(P<0.05),PHC组MTT小于其他两组(P<0.05);三组PS比较,差异无统计学意义(P>0.05)。②占位性病灶周围实质位置:HC组和ML组的HBF大于LH组,PHC组和ML组的HAF小于LH组,P<0.05;ML组的PS大于其他两组(P<0.05);三组HBV和MTT比较,差异无统计学意义(P>0.05)。③健康肝脏实质位置:PHC组MTT小于其他两组(P<0.05);PHC组HAF大于其他两组(P<0.05);三组HBV、PS、HBF比较,差异无统计学意义(P>0.05)。结论 采用CT灌注成像获得的参数能够很好地对LH与肝脏肿瘤进行监测与诊断
Abstract:
Objective To analyze the clinical value of multi-slice spiral CT in the diagnosis of hepatic hemangioma and liver tumor. Methods 96 patients with hepatic hemangioma and liver tumors admitted to our hospital from November 2015 to December 2017 were enrolled.The patients were divided into PHC group,ML group and LH group according to the disease type,32 cases in each group.Perfusion CT-type diagnostic monitoring was performed on the liver of all patients,and the parenchymal position,peripheral parenchymal position,and healthy liver parenchymal perfusion parameters(HBF,HBV,MTT,PS,HAF)of the three groups were compared. Results ①The location of the space-occupying lesions:The HBF and HAF of the PHC group were higher than the other two groups (P<0.05),the HBV of the PHC group and the LH group were larger than the ML group(P<0.05),the MTT of PHC group was lower than that of the other two groups(P<0.05);There was no significant difference in the three groups of PS (P>0.05).②The local location of the space-occupying lesions:The HBF of the HC group and the ML group was greater than that of the LH group,the HAF of the PHC group and the ML group was lower than that of the LH group,P<0.05;the PS of the ML group was larger than the other two groups(P<0.05);There was no significant difference between the three groups of HBV and MTT(P>0.05).③Healthy liver parenchymal position: MTT was lower in PHC group than in other two groups(P<0.05);HAF in PHC group was higher than other two groups(P<0.05);there was no significant difference in HBV,PS and HBF between the three groups(P>0.05).Conclusion The parameters obtained by CT perfusion imaging can well monitor and diagnose LH and liver tumors.

参考文献/References:

[1]史凤霞,刘建滨,郭一清.VIBE技术结合磁共振扩散加权成像对不典型肝血管瘤和肝细胞癌的鉴别诊断价值[J].中国CT和MRI杂志,2015,13(3):56-60. [2]季文斌,王卫珍,陈进,等.平阳霉素碘化油乳剂加明胶海绵颗粒栓塞法在肝血管瘤介入治疗中的疗效研究[J].解放军医学杂志,2015,40(6):513-514. [3]张绍祥,姜洪池,梁力建,等.计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中的应用专家共识[J].中国实用外科杂志,2017,37(5):531-538. [4]陈鹏,杨在宾,黄丽波,等.八角和杜仲叶提取物对断奶仔猪生长性能、血清酶活性及肝脏肿瘤坏死因子-α分布和表达的影响[J].动物营养学报,2017,29(3):874-881. [5]赵亮,曾帅,马鋆,等.彩色编码数字减影血管造影在定量分析化疗栓塞前后肝脏肿瘤灌注减少中的应用价值[J].介入放射学杂志,2017,26(4):313-317. [6]郭伟昌,彭翼,李昭辉,等.肝动脉介入栓塞化疗(TACE)联合门静脉栓塞(PVE)对兔移植性VX2肝肿瘤模型的肝脏增生的作用[J].世界最新医学信息文摘,2017,17(40):5-8.

相似文献/References:

[1]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及 肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
 WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Medical Information,2018,31(20):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[2]张 黎.中晚期原发性肝癌介入治疗的临床效果及对 肝功能的影响[J].医学信息,2018,31(09):20.[doi:10.3969/j.issn.1006-1959.2018.09.006]
 ZHANG Li.The Clinical Effect of Interventional Treatment of Primary Liver Cancer in Middle and Late Stage and its Effect on Liver Function[J].Medical Information,2018,31(20):20.[doi:10.3969/j.issn.1006-1959.2018.09.006]
[3]朱 瑞.血清AFP、CA19-9、CEA单项及三者联合检验对原发性肝癌早期诊断与治疗的意义对比[J].医学信息,2018,31(13):154.[doi:10.3969/j.issn.1006-1959.2018.13.047]
 ZHU Rui.Comparison of the Significance of Serum AFP,CA19-9,CEA Single and Combined the Three Methods Tests in the Early Diagnosis and Treatment of Primary Liver Cancer[J].Medical Information,2018,31(20):154.[doi:10.3969/j.issn.1006-1959.2018.13.047]
[4]侯宝松,王海峰,徐海晶,等.大黄蛰虫方合逍遥方加减对原发性肝细胞癌 TACE术后综合征影响[J].医学信息,2018,31(14):53.[doi:10.3969/j.issn.1006-1959.2018.14.017]
 HOU Bao-song,WANG Hai-feng,XU Hai-jing,et al.Effect of Rhubarb Aphid Fanghe Xiaoyaofang Decoction on Postoperative TACE Syndrome of Primary Hepatocellular Carcinoma[J].Medical Information,2018,31(20):53.[doi:10.3969/j.issn.1006-1959.2018.14.017]
[5]赵鱼扉,史政荣.肝脏储备功能临床应用研究[J].医学信息,2019,32(10):35.[doi:10.3969/j.issn.1006-1959.2019.10.013]
 ZHAO Yu-fei,SHI Zheng-rong.Clinical Application of Liver Reserve Function[J].Medical Information,2019,32(20):35.[doi:10.3969/j.issn.1006-1959.2019.10.013]
[6]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
 JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Medical Information,2019,32(20):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[7]邢时龙,淦 勤.原发性肝癌患者血清25-羟基维生素D3水平与免疫抑制因子IL-10的关系[J].医学信息,2020,33(01):101.[doi:10.3969/j.issn.1006-1959.2020.01.030]
 XING Shi-long,GAN Qin.Relationship Between Serum 25-hydroxyvitamin D3 Level and Immunosuppressive Factor IL-10 in Patients with Primary Liver Cancer[J].Medical Information,2020,33(20):101.[doi:10.3969/j.issn.1006-1959.2020.01.030]
[8]王瑞航,姚升娟,张 晨,等.肝动脉化疗栓塞介入术对原发性肝癌患者近期疗效及Child-Pugh分级的影响[J].医学信息,2020,33(17):101.[doi:10.3969/j.issn.1006-1959.2020.17.029]
 WANG Rui-hang,YAO Sheng-juan,ZHANG Chen,et al.Effect of Interventional Hepatic Artery Chemoembolization on the Short-term Efficacy and Child-Pugh Classification of Patients with Primary Liver Cancer[J].Medical Information,2020,33(20):101.[doi:10.3969/j.issn.1006-1959.2020.17.029]
[9]郑澹宁,孙国平.肝动脉化疗栓塞的肝癌患者生活质量调查研究[J].医学信息,2020,33(22):127.[doi:10.3969/j.issn.1006-1959.2020.22.036]
 ZHENG Dan-ning,SUN Guo-ping.Survey on the Quality of Life of Hepatocellular Cancer Patients Undergoing Transcatheter Arterial Chemoembolization[J].Medical Information,2020,33(20):127.[doi:10.3969/j.issn.1006-1959.2020.22.036]
[10]包学智.经肝动脉化疗栓塞联合射频消融术治疗中晚期原发性肝癌的效果[J].医学信息,2020,33(19):110.[doi:10.3969/j.issn.1006-1959.2020.19.033]
 BAO Xue-zhi.The Effect of Transhepatic Artery Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Advanced Primary Liver Cancer[J].Medical Information,2020,33(20):110.[doi:10.3969/j.issn.1006-1959.2020.19.033]

更新日期/Last Update: 2018-11-09